Cancer Centre Singapore (NCCS), which aims to use artificial intelligence (AI) based research to improve cancer care.
Hitachi High-Tech Corporation is now a partner with Invivoscribe, Inc., which provides blood cancer testing kits and services worldwide. The purpose behind the partnership is to speed up the molecular diagnostics and precision medicine businesses of both companies.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 4152
Published Date: May 24, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Growing adoption of advanced imaging technology, the rising prevalence of chronic diseases are the major factors driving the market growth.
The market size of mobile computed tomography scanners is anticipated to attain a CAGR of ~6% over the forecast period, i.e., 2023-2035.
Presence of alternate diagnostic imaging technologies and costly operation of mobile CT scanners.
The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
The major players in the market are Koninklijke Philips N.V., Hitachi Medical Corporation, United Imaging Healthcare Co., and others.
The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.
The market is segmented by technology, application, end user, and by region.
The neurology segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.